Understanding the causes of thrombotic microangiopathy in children after stem cell transplants

Initiators of thrombotic microangiopathy

NIH-funded research Cincinnati Childrens Hosp Med Ctr · NIH-10992178

This study is looking at a serious condition called thrombotic microangiopathy (TMA) that can affect kids after they have a stem cell transplant, and the researchers want to find out if viral infections, like BK polyomavirus, are triggers for this condition to help improve how we diagnose and treat it.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionCincinnati Childrens Hosp Med Ctr NIH-funded
Lab location1 site (Cincinnati, United States)
Project IDNIH-10992178 on NIH RePORTER

What this research studies

This research investigates thrombotic microangiopathy (TMA), a serious condition affecting children who have undergone hematopoietic stem cell transplants. The team aims to identify specific triggers for TMA, particularly focusing on the role of viral infections like BK polyomavirus. By analyzing blood samples and using advanced proteomic techniques, the researchers hope to uncover the mechanisms behind TMA and improve diagnostic criteria and treatment options. This work builds on previous findings that link complement dysregulation to TMA outcomes.

Who could benefit from this research

Good fit: Ideal candidates for this research are children under 11 years old who have undergone hematopoietic stem cell transplantation.

Not a fit: Patients who have not undergone hematopoietic stem cell transplantation or are older than 11 years may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to better prevention and treatment strategies for TMA, significantly improving survival rates for affected children.

How similar studies have performed: Previous research has shown promising results in understanding and managing TMA, particularly with the use of complement blockade, indicating that this area of study has potential for significant advancements.

Where this research is happening

Cincinnati, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Acute Graft Versus Host Diseaseacute graft vs host diseaseacute graft vs. host disease
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.